Selection of Additional Targets Sample Clauses

Selection of Additional Targets. During the period commencing on the Effective Date and ending on the date that is [***] thereafter (the “Additional Target Selection Period”), Biogen may select [***] additional targets (that are not Initial Targets) as Additional Targets hereunder (which such Additional Targets so selected pursuant to this sentence will be Initial Term Targets hereunder). In addition, if Biogen elects to extend the Collaboration Term for an additional [***] pursuant to Section 3.5.2 (Extension of Collaboration Term), then (A) upon such election, Biogen may select [***] additional targets as Additional Targets hereunder, and (B) during the period commencing on the date of such election and ending on the date that is [***] thereafter, Biogen may select [***] additional targets as Additional Targets hereunder (all of which such Additional Targets so selected pursuant to the foregoing clauses ((A) and (B)), will be Extended Term Targets hereunder), as described further in Section 3.5.3 (Effect of Extension of Initial Collaboration Term). Biogen may select each such Additional Target by sending a written notice to C4 during the Collaboration Term, which notice will identify the applicable proposed target (each, an “Additional Target Notice”).

Selection of Additional Targets. 33 4.4.2 Selection of Biomolecules as Compounds .................... 33 4.4.3

Selection of Additional Targets. During the Screening Phase, the JSC may select one or more additional Targets as Collaboration Targets against which to Screen Compounds for activity. Likewise, during the term of the Screening Program, the JSC may determine to discontinue Screening Compounds for activity against one or more Targets or to reinstate the screening of Compounds for activity against one or more Targets that were previously discontinued from Screening.

Selection of Additional Targets. Verastem will select the first Additional Target within [***] following the Effective Date and the second Additional Target within [***] following the Effective Date, in each case by providing written notice to GenFleet thereof. For clarity, Verastem may select the Additional Targets in a single notice or in two separate notices, so long as both Additional Targets are selected within the applicable timeframe set forth in this Section 5.1 (Selection of Additional Targets). Notwithstanding the forgoing, the timeframes for the selection of the Additional Targets set forth in this Section 5.1 (Selection of Additional Targets) will not apply to Verastem’s selection of any Additional Targets pursuant to Section 5.2 (Replacement Targets). Until the conclusion of the Selection Period, GenFleet will not license, partner, divest or otherwise encumber any of the targets included on the Available Target list without obtaining Verastem’s prior written consent.

Selection of Additional Targets. (a) During the Research Term and once the HSC Targets have been selected by the Parties pursuant to Section 2.2.3(a) [***], but in any event no later than [***] days prior to the expiration of the Research Term, Novartis will have the option to select up to an additional [***] HSC Targets (other than the Intellia Selected HSC Targets) on a non-exclusive basis (each, an “Additional Selected HSC Target”), subject to the payments set forth in Section 7.1.3. (b) For clarity, unless the Parties agree otherwise in writing, during the Research Term there will not be more than (i) [***] HSC Targets comprising the Novartis Selected HSC Targets; (ii) [***] HSC Targets comprising the Additional Novartis Selected HSC Targets; and (iii) [***] HSC Targets comprising the Intellia Selected HSC Targets.

Selection of Additional Targets